22-Feb-2021

Veterinary Vaccine Market will grow at 6.2% CAGR, to be valued at US$ 11,627.46 Million by 2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Veterinary Vaccine Market, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), By Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 6,766.5 million in 2018 and is expected to exhibit a CAGR of 6.2% over the forecast period (2020-2027).

Download Exclusive PDF Brochure of This Report: https://www.coherentmarketinsights.com/insight/request-sample/125

Various market players such as Zoetis, Inc., Regeneron Pharmaceuticals, Boehringer Ingelheim, and Merck are focusing on researches to understand the viral diseases, in order to develop vaccination for treating animals efficiently from various diseases. For instance, in June 2018, Regeneron Pharmaceuticals, Inc. and Zoetis, Inc. entered into a five-year collaboration to develop new veterinary medications by using Regeneron’s monoclonal antibody therapeutics in animals.

Moreover, in January 2017, Boehringer Ingelheim and Merial entered into a merger and opened a new R&D center. With the inauguration of the new integrated R&D Center, research teams from both companies joined their forces in the R&D Center, which leveraged the broad R&D expertise to create powerful collaboration in veterinary R&D capabilities.

Quick Buy – Veterinary Vaccine Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/125

Furthermore, in May 2018, Boehringer Ingelheim, initiated its new integrated Asian Veterinary Research & Development Centre in China to enhance its research and innovation capacity.

In addition, Aratana Therapeutics, Inc., AT-O14 vaccine is under clinical trials for canine osteosarcoma and similar vaccines in pipeline are expected to fuel growth of the veterinary vaccine market over the forecast period.

Additionally, market players are focused on adopting inorganic growth strategies such as acquisitions, in order to strengthen their market position, which is expected to drive growth of the market over the forecast period. For instance, in 2017, Merck Animal Health acquired Prondil S.A., which is dedicated in developing products for animal health care, especially vaccines to local and international markets. This acquisition aided Merck to add comprehensive portfolio of vaccines for livestock into their existing product portfolio.

Moreover, in 2017, Elanco, a subsidiary of Eli Lilly and Company acquired Boehringer Ingelheim Vetmedica, Inc.’s feline, canine, and rabies vaccines portfolio. This acquisition helped Elanco to expand its companion animal portfolio by including vaccines for bordetella, Lyme disease, feline leukemia, rabies, and parvovirus.

The rising number of research grants to introduce various anti-cancer therapies for veterinary cancer treatment is a major factor, which is expected to drive growth of the global veterinary vaccine market over the forecast period. For instance, in 2017, Animal Cancer Foundation (ACF) received US$ 1 million grant from the Blue Buffalo Foundation to support comparative oncology research to study similarities between naturally occurring cancers in people and pets, and develop effective treatment for both species. Moreover, in 2016, Petco Foundation and Blue Buffalo Foundation invested US$ 2.35 million to support pet cancer research and treatment, as it is a major cause of illness and premature death in affected species, across the globe.

Ask for Discount before buying the Report@ https://www.coherentmarketinsights.com/insight/talk-to-analyst/125

Key Takeaways of the Veterinary Vaccine Market:

The global veterinary vaccine market is expected to exhibit a CAGR of 6.2% over the forecast period (2020-2027), owing to increasing number of R&D initiatives for veterinary vaccine and acquisitions by market players
Among technology, inactivated vaccines segment is expected to account for a major revenue share, owing to increasing development of inactivated vaccines that contains killed pathogens, which cannot replicate and cause any diseases
Major players operating in the global veterinary vaccine market include Aratana Therapeutics, Inc., Regeneus Ltd., Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Zoetis, Inc., Eli Lilly and Company, Merck & Co., Inc., and Boehringer Ingelheim GmbH

Browse 25 Market Data Tables and 33 Figures spread through 220 Pages and in-depth TOC on “Veterinary Vaccine Market, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), by Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2027”

To know the latest trends and insights related to Veterinary Vaccine Market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/veterinary-vaccines-market-to-surpass-us-94-billion-by-2024-25

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Technology
  - Market Snippet, By Animal Type
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
- Impact Analysis
- Market Trends
- Epidemiology
- Initiatives for Prevention and Control of Pet Cancer
- Regulatory Guidelines
- Acquisitions
- Key Developments
- Nanotechnology in Veterinary Vaccinations
Global Veterinary Vaccine Market, By Technology, 2019 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Inactivated Vaccines
- Toxoid Vaccine
- Live Attenuated Vaccines
- Subunit and DNA Vaccines
Global Veterinary Vaccine Market, By Animal Type, 2019 – 2027, (US$ Million)
- Introduction
  - - Market Share Analysis, 2019 and 2027 (%)
    - Y-o-Y Growth Analysis, 2017 – 2027
    - Segment Trends
    - Companion
    - Equine
    - Canine
    - Feline
    - Livestock
    - Bovine
    - Ovine
    - Porcine
    - Poultry
    - Others
Global Veterinary Vaccine Market,, By Region, 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, By Region, 2017 – 2027
  - Regional Trends
- North America
  - Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Animal Type, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Animal Type, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Animal Type, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Animal Type, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Animal Type, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Animal Type, 2019 – 2027, (US$ Million)
  - Market Size and Forecast, By Country/Region, 2019 – 2027, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Aratana Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Regeneus Ltd.
  - Morphogenesis, Inc.
  - Karyopharm Therapeutics, Inc.
  - Zoetis, Inc.
  - Eli Lilly and Company
  - Merck & Co., Inc.
  - Boehringer Ingelheim GmbH
- Analyst Views
Section
- References
- Research Methodology
- About Us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 22-Feb-2021